The Novavax biotechnology company, based in Maryland, reported the results of its evacuation which, it is said, are 90% effective against covid-19.
The informants presented by the company are based on the clinical studies of the vacuna, one in the United Kingdom and another in South Africa, with around 20,000 participants.
Pharmaceuticals found that the vaccine was not effective against the variant first discovered in South Africa. The announcement is based on the fact that the EEUU reported its first cases of this variant in the country, in two persons not related to Carolina del Sur.
In the final exam in the United Kingdom, which includes 15,000 participants, 62 people will attend covid-19. 56 of them had received a placebo in the living room.
“These results are spectacular, and we have a lot of content to help with the development of this vaccine,” said Clive Dix, director of the team working to combat the coronavirus in the United Kingdom, through a communication. The British Governor supported the investigation.
“The efficient display has the new features and is also very attractive”, added. “It’s a great logo for insurers who can protect your virus from the people in it. United Kingdom and in the rest of the world ”.
The United States Governor has received $ 1,600 million to buy 100 doses of the vaccine from Novavax, which should be listed in the next few months.